MEDIFAST (MED)
(Delayed Data from NYSE)
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 5:54 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 5:54 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
Zacks News
Church & Dwight to Grow on Organic Sales, International Unit
by Zacks Equity Research
Church & Dwight's (CHD) stable portfolio of value and premium products, launch of innovative products and aggressive productivity programs are expected to keep driving its performance.
Retail Woes Hurt SUPERVALU (SVU), Wholesale Unit a Breather
by Zacks Equity Research
While SUPERVALU's (SVU) wholesale operations yield favorably, retail unit continues to reel under stiff competition.
Campbell (CPB) Q3 Earnings Beat, Stock Down on EPS View Cut
by Zacks Equity Research
Campbell (CPB) reports impressive bottom line in third-quarter fiscal 2018. However, management trims its earnings forecast for the fiscal year.
Why Celsius Holdings (CELH) Could Be Positioned for a Slump
by Zacks Equity Research
Celsius Holdings (CELH) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
Should You Add Conagra (CAG) to Your Portfolio Right Now?
by Zacks Equity Research
Conagra Brands (CAG) poised to grow on the back of brand modernizing moves, stronger innovation, buyouts, strategic divestments and lower tax rates.
Zacks.com highlights: Medifast, Myriad Genetics, ICU Medical, Ellie Mae and UGI
by Zacks Equity Research
Zacks.com highlights: Medifast, Myriad Genetics, ICU Medical, Ellie Mae and UGI
Is MEDIFAST (MED) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is MEDIFAST (MED) Outperforming Other Consumer Staples Stocks This Year?
Shrug Off Market Volatility With These 5 Low Beta Stocks
by Zacks Equity Research
We develop a strategy that clearly shows that less risky stocks have the potential to reward shareholders with impressive returns only when certain parameters are considered.
Companhia Brasileira Up 6.2% in a Month: Growth to Sustain?
by Zacks Equity Research
Companhia Brasileira (CBD) has been gaining from continued strength at Assai among other factors. However, the company continues to battle food deflation.
Solid Volumes Fuel Church & Dwight (CHD) Q1 Earnings & Sales
by Zacks Equity Research
Church & Dwight (CHD) posts solid Q1 results. Both earnings and sales rise year over year and beat expectations.
Zacks Investment Ideas feature highlights: CBOE Global Markets, ConAgra, SuperValu, United National Foods and Medifast
by Zacks Equity Research
Zacks Investment Ideas feature highlights: CBOE Global Markets, ConAgra, SuperValu, United National Foods and Medifast
Philip Morris (PM) Stock Loses 5% Despite Q1 Earnings Beat
by Zacks Equity Research
Philip Morris (PM) Q1 earnings and sales rise and management raises earnings view. However, sales continue to miss.
Hungry for Earnings Growth? Take a Look at These 4 Food Stocks
by David Borun
These Zacks Rank #1 food companies could be chicken soup for the investor's soul
Dean Foods (DF) Dips to 52-Week Low on Soft Milk Demand
by Zacks Equity Research
Dean Foods' (DF) weakening demand for milk, lower product volumes and higher raw milk costs have been taking a toll on the company.
Zacks.com highlights: US Foods Holding, Medifast, Marcus, Acushnet Holdings and Dine Brands Global
by Zacks Equity Research
Zacks.com highlights: US Foods Holding, Medifast, Marcus, Acushnet Holdings and Dine Brands Global
Market Volatility is Not a Worry With These 5 Low-Beta Stocks
by Zacks Equity Research
Successful investors never follow the crowd blindly for selecting lucrative stocks, and instead do their own research intensively.
5 Reasons Why Church & Dwight (CHD) Has More Room to Run
by Zacks Equity Research
We expect Church & Dwight's (CHD) strategic efforts like focus on buyouts to help offset the hurdles and fuel further growth at the company.
6 Stocks With Recent Price Strength to Maximize Your Returns
by Zacks Equity Research
Investors target stocks that have been on a bull run of late. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Why Kellogg (K) is an Attractive Pick for Investors Now
by Zacks Equity Research
Kellogg's (K) higher focus on brand building, cost-saving initiatives and expansion into emerging markets are likely to drive growth.
Sysco Gains 18% in a Year: U.S. Foodservice the Sole Driver?
by Zacks Equity Research
Sysco's (SYY) U.S. Foodservice unit has been gaining from solid brand strength, thanks to the impressive product assortment; focus on brand revitalization and innovations.
Campbell (CPB) Restructures Business, Forms Accelerator Unit
by Zacks Equity Research
Campbell's (CPB) strategic reorganization to adapt to the fast changing food industry is encouraging. Also, the company has created a new accelerator unit to boost growth in its faster-growing business.
Zacks.com highlights: Medifast, LCI Industries, Patrick Industries, Vectrus and Calavo Growers
by Zacks Equity Research
Zacks.com highlights: Medifast, LCI Industries, Patrick Industries, Vectrus and Calavo Growers
Dig Into DuPont Technique to Grab 5 Quality Picks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Earnings Estimates Moving Higher for Medifast (MED): Time to Buy?
by Zacks Equity Research
Medifast (MED) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision in addition to having decent short-term momentum.
Medifast, Signet Jewelers and NVIDIA highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Medifast, Signet Jewelers and NVIDIA highlighted as Zacks Bull and Bear of the Day